Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults.

A single dose (5 x 10(8) organisms) of attenuated A- B+ Vibrio cholerae classical Inaba recombinant vaccine strain CVD 103-HgR or placebo was administered to 24 healthy young Thai adults in a randomized, placebo-controlled, double-blind trial of safety and immunogenicity. None of the volunteers expe...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Infect Immun
Asıl Yazarlar:	Migasena, S, Pitisuttitham, P, Prayurahong, B, Suntharasamai, P, Supanaranond, W, Desakorn, V, Vongsthongsri, U, Tall, B, Ketley, J, Losonsky, G
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1989
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC259791/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2807523/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.57.11.3261-3264.1989
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults.

Benzer Materyaller